These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Optimizing Salmonella enterica serovar Typhimurium for bacteria-mediated tumor therapy. Felgner S; Kocijancic D; Frahm M; Curtiss R; Erhardt M; Weiss S Gut Microbes; 2016; 7(2):171-7. PubMed ID: 26939530 [TBL] [Abstract][Full Text] [Related]
8. Optimized Attenuated Liang K; Zhang R; Luo H; Zhang J; Tian Z; Zhang X; Zhang Y; Ali MK; Kong Q Front Microbiol; 2021; 12():774490. PubMed ID: 35003007 [TBL] [Abstract][Full Text] [Related]
9. Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter. Huang Y; Hajishengallis G; Michalek SM Infect Immun; 2001 Apr; 69(4):2154-61. PubMed ID: 11254570 [TBL] [Abstract][Full Text] [Related]
10. Use of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in mice. Gentschev I; Fensterle J; Schmidt A; Potapenko T; Troppmair J; Goebel W; Rapp UR BMC Cancer; 2005 Feb; 5():15. PubMed ID: 15703070 [TBL] [Abstract][Full Text] [Related]
11. Phenotypic evolution of therapeutic Salmonella enterica serovar Typhimurium after invasion of TRAMP mouse prostate tumor. Choe E; Kazmierczak RA; Eisenstark A mBio; 2014 Jul; 5(4):e01182-14. PubMed ID: 24987088 [TBL] [Abstract][Full Text] [Related]
12. Efficiency of conditionally attenuated Salmonella enterica serovar Typhimurium in bacterium-mediated tumor therapy. Frahm M; Felgner S; Kocijancic D; Rohde M; Hensel M; Curtiss R; Erhardt M; Weiss S mBio; 2015 Apr; 6(2):. PubMed ID: 25873375 [TBL] [Abstract][Full Text] [Related]
13. An attenuated Salmonella enterica serovar Typhimurium strain lacking the ZnuABC transporter induces protection in a mouse intestinal model of Salmonella infection. Pesciaroli M; Aloisio F; Ammendola S; Pistoia C; Petrucci P; Tarantino M; Francia M; Battistoni A; Pasquali P Vaccine; 2011 Feb; 29(9):1783-90. PubMed ID: 21219981 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of immune responses by an attenuated Salmonella enterica serovar Typhimurium strain secreting an Escherichia coli heat-labile enterotoxin B subunit protein as an adjuvant for a live Salmonella vaccine candidate. Hur J; Lee JH Clin Vaccine Immunol; 2011 Feb; 18(2):203-9. PubMed ID: 21159921 [TBL] [Abstract][Full Text] [Related]
16. Local application of bacteria improves safety of Salmonella -mediated tumor therapy and retains advantages of systemic infection. Kocijancic D; Felgner S; Schauer T; Frahm M; Heise U; Zimmermann K; Erhardt M; Weiss S Oncotarget; 2017 Jul; 8(30):49988-50001. PubMed ID: 28637010 [TBL] [Abstract][Full Text] [Related]
17. Characterization of an outer membrane protein of Salmonella enterica serovar typhimurium that confers protection against typhoid. Hamid N; Jain SK Clin Vaccine Immunol; 2008 Sep; 15(9):1461-71. PubMed ID: 18650399 [TBL] [Abstract][Full Text] [Related]
18. Characterization of a highly attenuated Salmonella enterica serovar Typhimurium mutant strain. Tang IK; Ji DD; Chou CF; Lin HC; Liao CL; Sytwu HK; Wang JJ; Liu YT J Microbiol Immunol Infect; 2002 Dec; 35(4):229-35. PubMed ID: 12542248 [TBL] [Abstract][Full Text] [Related]
19. Analysis of Spleen-Induced Fimbria Production in Recombinant Attenuated Łaniewski P; Baek CH; Roland KL; Curtiss R mBio; 2017 Aug; 8(4):. PubMed ID: 28830946 [No Abstract] [Full Text] [Related]
20. Levels of expression and immunogenicity of attenuated Salmonella enterica serovar typhimurium strains expressing Escherichia coli mutant heat-labile enterotoxin. Covone MG; Brocchi M; Palla E; Dias da Silveira W; Rappuoli R; Galeotti CL Infect Immun; 1998 Jan; 66(1):224-31. PubMed ID: 9423862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]